⌘K

Login Start Free

Home/Filings/4/0001181431-10-011332

4//SEC Filing

MARTIN J TYLER 4

Accession 0001181431-10-011332

CIK 0001029142other

View on SEC.gov Company Profile

Filed

Feb 22, 7:00 PM ET

Accepted

Feb 23, 5:18 PM ET

Size

5.7 KB

Accession

0001181431-10-011332

Insider Transaction Report

Form 4

Period: 2010-02-19

DYNAVAX TECHNOLOGIES CORPDVAX

VP Clinical Development & CMO

Transactions

Award
Option (Right to Buy)
2010-02-19+50,000→ 50,000 total
Exercise: $1.58Exp: 2020-02-18→ Common Stock (50,000 underlying)

Footnotes (2)

[F1]This option grant shall vest upon achievement of certain performance conditions.
[F2]Not applicable.

Documents

1 file

4
rrd267238.xmlPrimary
FORM 4

Issuer

DYNAVAX TECHNOLOGIES CORP

CIK 0001029142

Entity typeother

Related Parties

1

filerCIK 0001234388

Filing Metadata

Form type: 4
Filed: Feb 22, 7:00 PM ET
Accepted: Feb 23, 5:18 PM ET
Size: 5.7 KB

View on SEC.gov